Depression, vertigo, headaches and stroke were among conditions linked to early-onset Alzheimer's disease years before ...

Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that ...

The compound is still only in mice, but it works through a very different route than today’s approved Alzheimer’s infusions.

Shanghai Fosun Pharmaceuticals secured regional rights to AR1001 via a $60M option fee. Find out why SFOSF stock is a hold.

Early-onset Alzheimer's differs from late-onset, with distinct preceding health issues and no extra cardiovascular risk, per ...

Dementia and Alzheimer’s disease are closely related, but the terms describe different things. Dementia is a pattern of problems with memory, thinking or behaviour that interferes with daily life, ...

Experimental compounds have reduced the production of an Alzheimer’s-linked protein and lowered brain plaque levels in mice.

Learn how Alzheimer's disease is diagnosed through history, testing, imaging, and emerging blood biomarkers to support early ...

Arrowhead Pharmaceuticals, Inc. on Wednesday shared interim data from an ongoing Phase 1/2a clinical trial for ARO-MAPT, an investigational RNA interference therapy targeting Alzheimer’s disease and ...

A study of two different cancer drugs in mice showed promise for reversing Alzheimer's brain damage. Scientists are hopeful the same happens in human trials.

The FDA has approved a blood test to help diagnose Alzheimer's disease, and doctors explain how it works and why it can lead ...

A new report argues that more flexible eligibility criteria could widen pharma’s clinical trial pool without sacrificing ...